Webinar Date/Time: Tuesday, June 25th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST
Related Posts
Phase III Trial Data Reinforce Potential of Imfinzi and Lynparza and Imfinzi Regimen for Endometrial Cancer
Image Credit: © LASZLO – stock.adobe.com Analysis of results from the DUO-E Phase III trial have reinforced the potential of…
Elrexfio Shows Deep and Durable Responses Extending Survival in Relapsed or Refractory Multiple Myeloma
Image credit: LASZLO | stock.adobe.com Findings from the Phase II MagnetisMM-3 trial (NCT04649359) showed a significant survival benefit with Elrexfio…
FDA Reaches Agreement on Endpoints for Approval of Budiodarone for the Management of Atrial Fibrillation
Image Credit: © photon_photo – stock.adobe.com XYRA has announced that it has reached an agreement with FDA on the key…